“… Xu et al [ 21 ] | Five-year | 16 features | Yes (Univariate and multivariate regression analysis) | clinicopathological characteristics and follow-up data of ESCC patients at the Department of Thoracic Surgery in Northern Jiangsu People's Hospital | Gender, age, type of surgery, hypertension, diabetes, smoking, drinking, tumor size, tumor center location, histological grade, PT stage, pN stage, vascular invasion, nerve invasion, pathological types, surgical margins, | 810 patients with ESCC | Decision tree, RF, SVM, GBM, XG-Boost | No | The XG-Boost model with (AUC = 0.855; 95% CI, 0.808–0.902) was considered optimal. |
Zhang et al [ 35 ] | Three-year and five-year survival | 27 features | Yes (LASSO regularization and univariable Cox regression analysis) | One single-center database of Sichuan Cancer Hospital | Age, sex, Karnofsky performance scale score, tumor length, tumor grade, tumor location, vascular invasion, surgical margin, dissected lymph nodes number, nerve invasion, T stage, N stage, AJCC8th stage, surgical intervention alone, hematocrit, mean platelet volume, neutrophil to lymphocyte ratio, monocytes, eosinophil, direct bilirubin, albumin, aspartate aminotransferase, alkaline phosphatase, sodium, magnesium, fibrinogen, lymphocyte -to- monocytes ratio | 2441 ESCC patients | R-part, Elastic Net, GBM, RF, GLMboost, and ML-extended CoxPH method | No | ML-extended CoxPH has a 75.4%, 45.8%, and 26.9% prediction capability for stratifying the low, medium, and high-risk groups for three-year survival. Also, it gained 65.3%, 29.7%, and 11% for 5-year survival. |
…”